Hersh Kozlov - Jul 1, 2022 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Director
Signature
/s/ Richard S. Nelson as Attorney-in-Fact
Stock symbol
VTVT
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
4
Date filed
7/6/2022, 04:13 PM
Previous filing
May 26, 2022
Next filing
May 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTVT Director stock option (right to buy) Award $0 +105K $0.00 105K Jul 1, 2022 Class A Common Stock 105K $0.72 Direct F1
holding VTVT Director stock option (right to buy) 26.3K Jul 1, 2022 Class A Common Stock 26.3K $2.65 Direct F2, F3
holding VTVT Director stock option (right to buy) 15K Jul 1, 2022 Class A Common Stock 15K $2.54 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 An option to purchase 80,128 shares vested immediately on July 1, 2022. The remaining option to purchase 25,000 shares vests on June 1, 2023.
F2 On June 15, 2020 and May 5, 2021, the reporting person filed Form 4s which inadvertently aggregated options to purchase shares of Class A common stock with different exercise prices and expiration dates. These errors have been corrected in the options beneficially owned in this Form 4.
F3 An option to purchase 2,812 shares vested immediately on June 11, 2020. The remaining option to purchase 23,438 shares vests in equal monthly installments over the three-year period beginning on June 11, 2020.
F4 Vests in equal monthly installments over the three-year period beginning May 3, 2021.